Takashi Yamaoka | Yamaoka Clinic

スポンサーリンク

概要

関連著者

もっと見る

著作論文

A New Antitumor Agent Amrubicin Induces Cell Growth Inhibition by Stabilizing Topoisomerase II-DNA Complex
Effect of +36T > C in intron 1 on the glutamine : fructose-6-phosphate amidotransferase 1 gene and its contribution to type 2 diabetes in different populations
SNPs in the KCNJ11-ABCC8 gene locus are associated with type 2 diabetes and blood pressure levels in the Japanese population
No evidence for association of the ENPP1 (PC-1) K121Q variant with risk of type 2 diabetes in a Japanese population
Infrequent Detectable Somatic Mutations of the RET and Glial Cell Line-derived Neurotrophic Factor (GDNF) Genes in Human Pituitary Adenomas
The Rate of Cell Growth Is Regulated by Purine Biosynthesis via ATP Production and G1 to S Phase Transition
Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of human hepatoma cells orthotopically implanted in nude rats
Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo
Amrubicin induces apoptosis in human tumor cells mediated by the activation of caspase-3/7 preceding a loss of mitochondrial membrane potential
Uptake and Intracellular Distribution of Amrubicin, a Novel 9-Amino-anthracycline, and Its Active Metabolite Amrubicinol in P388 Murine Leukemia Cells
Cytotoxicity of Amrubicin, a Novel 9-Aminoanthracycline, and Its Active Metabolite Amrubicinol on Human Tumor Cells
Tumor-selective Distribution of an Active Metabolite of the 9-Aminoanthracycline Amrubicin
In vivo Efficacy and Tumor-selective Metabolism of Amrubicin to Its Active Metabolite
Expression of somatostatin receptor subtypes and growth inhibition in human exocrine pancreatic cancers

もっと見る

スポンサーリンク